| Metric | FY 2024↕ | FY 2015↕ | FY 2014↕ | FY 2013↕ | FY 2012↕ | FY 2011↕ |
|---|---|---|---|---|---|---|
| Revenue | $14.1B | — | — | — | — | — |
| Cost of Revenue | $12.2B | — | — | — | — | — |
| Gross Profit | $1.9B | $0.5B | $0.5B | $0.3B | $0.3B | $1.7B |
| R&D Expense | $0.1B | — | — | $0.1B | $0.1B | — |
| SG&A Expense | $0.8B | — | — | $0.8B | $0.8B | $0.8B |
| Operating Income | $1.1B | $0.3B | $0.2B | $0.1B | $0.2B | $1.1B |
| Net Income | $1.0B | $0.2B | $0.2B | $0.0B | $0.1B | $0.5B |
| EPS (Basic) | $2.51 | — | — | $0.21 | $0.50 | $3.14 |
| EPS (Diluted) | $2.51 | — | — | $0.21 | $0.49 | $3.12 |
| Metric | FY 2024↕ | FY 2015↕ | FY 2014↕ | FY 2013↕ | FY 2012↕ | FY 2011↕ |
|---|---|---|---|---|---|---|
| Total Assets | $11.1B | $9.9B | $10.1B | $7.7B | $7.4B | $7.6B |
| Current Assets | $4.2B | — | — | $3.6B | $3.3B | $3.3B |
| Cash & Equivalents | — | — | — | $0.3B | $0.3B | $0.4B |
| Total Liabilities | — | — | — | — | — | — |
| Current Liabilities | $1.7B | — | — | $1.7B | $1.1B | $1.2B |
| Stockholders' Equity | $5.8B | — | — | $3.1B | $3.4B | $3.5B |
| Metric | FY 2024↕ | FY 2015↕ | FY 2014↕ | FY 2013↕ | FY 2012↕ | FY 2011↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | $0.2B | — | — |
| Investing Cash Flow | — | — | — | — | — | — |
| Capital Expenditures | — | — | $0.3B | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | — | — | — | — | — | — |